Literature DB >> 20644467

De-novo thrombolysis for recurrent stroke in a patient with prior history of thrombolysis.

Ethem Murat Arsava1, Mehmet Akif Topcuoglu.   

Abstract

A 67-year-old male with prior history of atrial fibrillation was admitted to our center with acute onset of aphasia. He was treated by intravenous thrombolysis. Approximately 2 years later he presented with left-sided weakness, and was again treated with intravenous tissue plasminogen activator (iv-tPA). The patient responded favorably to thrombolytics on both occasions, without significant complications and with satisfactory recovery. Although there is no apparent reason to withhold thrombolysis in stroke patients with prior history of iv-tPA treatment, experience regarding the use of repeated thrombolysis in recurrent stroke is under-reported in the literature. This study, although reflecting experience from a single case, highlights that repeated administration of iv-tPA is well tolerated in stroke patients with late recurrences and previous history of thrombolysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644467     DOI: 10.1097/MBC.0b013e32833c2b3c

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  3 in total

1.  Thrombolysis of a stroke patient with history of rtPA-associated angioedema.

Authors:  Felipe De Los Rios La Rosa; Amy K Starosciak; Brian Wolf
Journal:  Neurol Clin Pract       Date:  2017-12

2.  Repeated thrombolytic therapy in patients with recurrent acute ischemic stroke.

Authors:  Han Soo Yoo; Young Dae Kim; Hye Sun Lee; Dongbeom Song; Tae Jin Song; Byung Moon Kim; Dong Joon Kim; Dong Ik Kim; Ji Hoe Heo; Hyo Suk Nam
Journal:  J Stroke       Date:  2013-09-27       Impact factor: 6.967

3.  Adverse outcome of early recurrent ischemic stroke secondary to atrial fibrillation after repeated systemic thrombolysis.

Authors:  Luciano A Sposato; Valeria Salutto; Diego E Beratti; Paula Monti; Patricia M Riccio; Claudio Mazia
Journal:  Case Rep Vasc Med       Date:  2013-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.